Novartis Receives Positive CHMP Opinion for Fabhalta PNH Therapy
Novartis receives positive CHMP opinion for Fabhalta® as first oral monotherapy for PNH in adults.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
